Reduced cell replication and induction of apoptosis by advanced glycation end products in rat Schwann cells

被引:131
作者
Sekido, H [1 ]
Suzuki, T
Jomori, T
Takeuchi, M
Yabe-Nishimura, C
Yagihashi, S
机构
[1] Sanwa Kagaku Kenkyusho Co Ltd, Drug Dev Res Labs, Inabe, Japan
[2] Hokuriku Univ, Fac Pharmaceut Sci, Dept Biochem, Kanazawa, Ishikawa, Japan
[3] Kyoto Prefectural Univ Med, Dept Pharmacol, Kyoto, Japan
[4] Hirosaki Univ, Sch Med, Dept Pathol, Hirosaki, Aomori, Japan
关键词
diabetic neuropathy; advanced glycation end products; Schwann cell; apoptosis;
D O I
10.1016/j.bbrc.2004.05.159
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We investigated the effects of advanced glycation end products (AGEs) derived from glucose, glyceraldehyde, and glycolaldehyde (designated as AGE-1, -2, and -3, respectively) on the viability, replication rate, and cytokine production of cultured Schwann cells. AGE-2 and -3, but not AGE-1, induced apoptosis, and significantly decreased the viability measured by MTT assay. The decrease was prevented completely by antioxidant a-lipoic acid and was prevented partially by p38 mitogen-activated protein kinase inhibitor SB202190. The decrease in mitochondrial membrane potential by AGE-2 and -3 was also observed. In addition, AGE-2 and -3 significantly suppressed the replication rate as shown by reduced bromodeoxyuridine uptake, whereas they enhanced the release of TNF-alpha and IL-1beta into the medium and activated nuclear factor-kappaB. The effects of AGE-1 on these measures were equivocal. The series of events elicited by AGE-2 and -3 may be responsible for some of the aspects of pathogenetic mechanisms in patients with diabetic neuropathy. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:241 / 248
页数:8
相关论文
共 33 条
[1]   NF-κB activation [J].
Abraham, E .
CRITICAL CARE MEDICINE, 2000, 28 (04) :N100-N104
[2]   Role of oxidative stress in diabetic complications - A new perspective on an old paradigm [J].
Baynes, JW ;
Thorpe, SR .
DIABETES, 1999, 48 (01) :1-9
[3]   Biochemistry and molecular cell biology of diabetic complications [J].
Brownlee, M .
NATURE, 2001, 414 (6865) :813-820
[4]   EFFECTS OF AMINOGUANIDINE ON PERIPHERAL-NERVE FUNCTION AND POLYOL PATHWAY METABOLITES IN STREPTOZOTOCIN-DIABETIC RATS [J].
CAMERON, NE ;
COTTER, MA ;
DINES, K ;
LOVE, A .
DIABETOLOGIA, 1992, 35 (10) :946-950
[5]   Toxic action of advanced glycation end products on cultured retinal capillary pericytes and endothelial cells: Relevance to diabetic retinopathy [J].
Chibber, R ;
Molinatti, PA ;
Rosatto, N ;
Lambourne, B ;
Kohner, EM .
DIABETOLOGIA, 1997, 40 (02) :156-164
[6]   Pathologic alterations in the diabetic neuropathies of humans: A review [J].
Dyck, PJ ;
Giannini, C .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1996, 55 (12) :1181-1193
[7]   THE FATE OF SCHWANN-CELL BASEMENT-MEMBRANES IN PERMANENTLY TRANSECTED NERVES [J].
GIANNINI, C ;
DYCK, PJ .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1990, 49 (06) :550-563
[8]   Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy [J].
Hammes, HP ;
Du, XL ;
Edelstein, D ;
Taguchi, T ;
Matsumura, T ;
Ju, QD ;
Lin, JH ;
Bierhaus, A ;
Nawroth, P ;
Hannak, D ;
Neumaier, M ;
Bergfeld, R ;
Giardino, I ;
Brownlee, M .
NATURE MEDICINE, 2003, 9 (03) :294-299
[9]   Advanced glycation end products induce expression of vascular endothelial growth factor by retinal Muller cells [J].
Hirata, C ;
Nakano, K ;
Nakamura, N ;
Kitagawa, Y ;
Shigeta, H ;
Hasegawa, G ;
Ogata, M ;
Ikeda, T ;
Sawa, H ;
Nakamura, K ;
Ienaga, K ;
Obayashi, H ;
Kondo, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 236 (03) :712-715
[10]  
JOHNSON PC, 1981, LAB INVEST, V44, P265